article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.

Vaccines 387
article thumbnail

ICH Q6(R1): test criteria and specifications

European Pharmaceutical Review

EMA/CHMP/ICH/214732/2007. Internet] Vaccines Europe. ICH Q9(R1) Quality Risk Management – Scientific Guideline. 3 February 2023. EMA/CHMP/ICH/24235/2006. ICH Q10 Pharmaceutical Quality System – Scientific Guideline. September 2015. November 2012. EMA/CHMP/ICH/425213/2011. J Pharm Sci. 2024; 113: 837-855. 25 June 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

At the same time, there were multiple competing priorities, such as managing the bone infection caseloads, implementing changes to departmental IPC practice, vaccination programmes and new COVID-19 treatments. Like all AMS teams, trying to be agile and respond to this change has been an enormous challenge.

Hospitals 147
article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

The progress of the RNA technology and tumour specific vaccination will be also key to increase adaptive immunity against the tumour but also as it participates to the activation of the innate immunity through RNA sensing. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.

article thumbnail

A history of AstraZeneca

pharmaphorum

In 2007, AstraZeneca’s pipeline was the subject of much speculation, as the company began to face increasing pressure from generics as many of its key drugs began to reach patent expiry. In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2

article thumbnail

First continuous mRNA manufacturing platform to be developed

European Pharmaceutical Review

This $85 million programme ran between 2007 and 2019. Moderna’s mRNA vaccine manufacturing centre begins construction … The post First continuous mRNA manufacturing platform to be developed appeared first on European Pharmaceutical Review.

FDA 98
article thumbnail

Record number of health firms feature in UK top 100 private tech list

pharmaphorum

There are pharma companies on the list, including Kymab , which at number 87 is working with the Bill & Melinda Gates Foundation to test several potential vaccines. Also on the list is Faculty, which at number 33 provides accurate and timely information used by decision-makers in the NHS and the government.